FDA permits Artificial intelligence-based in diabetes-related eye problems

The U.S. Food and Drug Administration has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. 

The device, called IDx-DR, is a software program that uses an artificial intelligence algorithm to analyze images of the eye taken with a retinal camera called the Topcon NW400. 

IDx-DR is the first device authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results, which makes it usable by health care providers who may not normally be involved in eye care.

Is this the beginning of the new era of AI in healthcare?

Reference and Further Reading

FDA News Room

Famous Radiology Blog https://ift.tt/1MM2hKr TeleRad Providers at https://ift.tt/1NgppuI Mail us at sales@teleradproviders.com

from Imaging via alkiviadis.1961 on Inoreader https://ift.tt/2JHqhz5